Aquila Bioscience has a team of experts from a range of science diciplines, bridging Glycobiology, Immunology, Microbiology, Biochemistry and Analytical Chemistry, providing the highest quality of services and products to its customers.
Research interests lie in the fight against chronic and infectious diseases.

Cell-based assays:

Cell-based potency assays, or bioassays, are becoming an indispensable method for testing a compounds biological activity.Defining a compounds ability to elicit a particular response at a particular concentration is essential when establishing its safety and efficacy. Unlike animal based testing, cell-based potency assays can be performed in a relatively short period of time, is cost effective and deters ethical issues that often arise with animal testing.

The testing of synthetic, biological or natural compounds for specific biological activity is an essential step in product development and manufacturing. It provides the quality assurance needed for the release of regulated products such as biopharmaceuticals, pharmaceuticals and vaccines. In addition, the use of bioassays to support bioactivity claims on nutraceutical and cosmetic products offers companies a huge marketing advantage over competitors, ensuring customers are receiving a functional, high quality product.

Aquila Bioscience hosts a team of Ph.D level scientists with extensive experience in bioassay and immunoassay development. To complement our cell-based assay services, Aquila Bioscience offers a full range of analytical services to investigate the effect of a compound, protein or gene on downstream signalling pathways. Our molecular biology team offers customers a full range of techniques to analyse protein and RNA expression.

Our team of experts are always happy to discuss your particular needs and determine the best experimental approach to achieve complete customer satisfaction.

  • Toxicity Assays:
  • Proliferation Assays:
  • Immunomodulation Assays:
  • Gene expression studies - Transfection/Transduction:
  • Reporter gene studies:
  • Custom assay development:
  • Full range of analytical techniques:


AquilaBio News

-Jan 05th 2015: Aquila Bioscience sign contract with the European Defense Agency

-Nov 18th 2014: The Natural Product Biotechnology conference

- Oct 13th 2014: Aquila Bioscience meet with NAPES

-Sep 23rd 2014: Aquila Bioscience has been shortlisted in three categories